Role of cyclin polymorphisms in predicting outcome of 5-fluorouracil-based chemotherapy in colorectal cancer: one piece in a complex puzzle

Melissa J LaBonte; Heinz-Josef Lenz; Melissa LaBonte Wilson

doi:10.2217/pgs.13.138

Role of cyclin polymorphisms in predicting outcome of 5-fluorouracil-based chemotherapy in colorectal cancer: one piece in a complex puzzle

Melissa J LaBonte, Heinz-Josef Lenz, Melissa LaBonte Wilson

School of Medicine, Dentistry and Biomedical Sciences

Research output: Contribution to journal › Article › peer-review

2 Citations (Scopus)

Original language	English
Pages (from-to)	1671-4
Number of pages	4
Journal	Pharmacogenomics
Volume	14
Issue number	14
DOIs	https://doi.org/10.2217/pgs.13.138
Publication status	Published - Nov 2013

Keywords

Colorectal Neoplasms
Cyclin D
Fluorouracil
Humans
Polymorphism, Single Nucleotide

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.2217/pgs.13.138

Cite this

@article{6023c5130f57439cb787e7d146a11a86,

title = "Role of cyclin polymorphisms in predicting outcome of 5-fluorouracil-based chemotherapy in colorectal cancer: one piece in a complex puzzle",

keywords = "Colorectal Neoplasms, Cyclin D, Fluorouracil, Humans, Polymorphism, Single Nucleotide",

author = "LaBonte, \{Melissa J\} and Heinz-Josef Lenz and \{LaBonte Wilson\}, Melissa",

year = "2013",

month = nov,

doi = "10.2217/pgs.13.138",

language = "English",

volume = "14",

pages = "1671--4",

journal = "Pharmacogenomics",

issn = "1462-2416",

publisher = "Taylor and Francis",

number = "14",

}

TY - JOUR

T1 - Role of cyclin polymorphisms in predicting outcome of 5-fluorouracil-based chemotherapy in colorectal cancer: one piece in a complex puzzle

AU - LaBonte, Melissa J

AU - Lenz, Heinz-Josef

AU - LaBonte Wilson, Melissa

PY - 2013/11

Y1 - 2013/11

KW - Colorectal Neoplasms

KW - Cyclin D

KW - Fluorouracil

KW - Humans

KW - Polymorphism, Single Nucleotide

U2 - 10.2217/pgs.13.138

DO - 10.2217/pgs.13.138

M3 - Article

C2 - 24192114

SN - 1462-2416

VL - 14

SP - 1671

EP - 1674

JO - Pharmacogenomics

JF - Pharmacogenomics

IS - 14

ER -